DK1280558T3 - Halvfast indgivelsesvehikel og farmaceutiske sammensætninger - Google Patents

Halvfast indgivelsesvehikel og farmaceutiske sammensætninger

Info

Publication number
DK1280558T3
DK1280558T3 DK01935418T DK01935418T DK1280558T3 DK 1280558 T3 DK1280558 T3 DK 1280558T3 DK 01935418 T DK01935418 T DK 01935418T DK 01935418 T DK01935418 T DK 01935418T DK 1280558 T3 DK1280558 T3 DK 1280558T3
Authority
DK
Denmark
Prior art keywords
semi
pharmaceutical compositions
administration vehicle
solid administration
solid
Prior art date
Application number
DK01935418T
Other languages
Danish (da)
English (en)
Inventor
Steven Y Ng
Jorge Heller
Hui-Rong Shen
Original Assignee
Ap Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ap Pharma Inc filed Critical Ap Pharma Inc
Application granted granted Critical
Publication of DK1280558T3 publication Critical patent/DK1280558T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
DK01935418T 2000-05-11 2001-05-11 Halvfast indgivelsesvehikel og farmaceutiske sammensætninger DK1280558T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56971700A 2000-05-11 2000-05-11

Publications (1)

Publication Number Publication Date
DK1280558T3 true DK1280558T3 (da) 2005-12-27

Family

ID=24276565

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01935418T DK1280558T3 (da) 2000-05-11 2001-05-11 Halvfast indgivelsesvehikel og farmaceutiske sammensætninger

Country Status (8)

Country Link
EP (1) EP1280558B1 (de)
AT (1) ATE311904T1 (de)
AU (1) AU2001261516A1 (de)
CA (1) CA2445638C (de)
DE (1) DE60115631T2 (de)
DK (1) DK1280558T3 (de)
ES (1) ES2253381T3 (de)
WO (1) WO2001085139A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050042194A1 (en) * 2000-05-11 2005-02-24 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
US20020176844A1 (en) * 2001-05-11 2002-11-28 Ng Steven Y. Bioerodible polyorthoesters containing hydrogen bonding groups
WO2002092661A1 (en) * 2001-05-11 2002-11-21 Ap Pharma, Inc. Peg-poe, peg-poe-peg, and poe-peg-poe block copolymers
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
US7045589B2 (en) 2002-11-15 2006-05-16 A.P. Pharma, Inc. Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them
WO2006036936A2 (en) 2004-09-27 2006-04-06 Bridge Pharma, Inc. The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
EP2044142A2 (de) 2006-06-29 2009-04-08 Medtronic, Inc. Poly(orthoester)polymere sowie herstellungs- und verwendungsverfahren dafür
CA2655809C (en) 2006-07-21 2013-10-01 Bridge Pharma, Inc. Dermal anesthetic compounds
US8475823B2 (en) 2008-04-18 2013-07-02 Medtronic, Inc. Baclofen formulation in a polyorthoester carrier
US8956642B2 (en) 2008-04-18 2015-02-17 Medtronic, Inc. Bupivacaine formulation in a polyorthoester carrier
CA2906666C (en) * 2013-03-15 2019-12-24 Heron Therapeutics, Inc. Compositions of a polyorthoester and an aprotic solvent
US10980886B2 (en) * 2014-04-21 2021-04-20 Heron Therapeutics, Inc. Compositions of a polyorthoester and an organic acid excipient
WO2021146215A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
WO2022152835A1 (en) * 2021-01-18 2022-07-21 Evonik Operations Gmbh High molecular weight triethylene-glycol polyorthoester iv (teg-poe iv) polymers and compositions for drug delivery and medical implants applications
WO2023137659A1 (zh) * 2022-01-20 2023-07-27 南京泛太化工医药研究所 一种具有酸敏感降解、温敏性质的系列聚合物及其载药组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT99989A (pt) * 1991-01-09 1994-05-31 Alza Corp Dispositivos biodegradaveis e composicoes para libertacao difusivel de agentes
MY113268A (en) * 1992-12-29 2002-01-31 Insite Vision Incorporated Plasticized bioerodible controlled delivery system
US5968543A (en) * 1996-01-05 1999-10-19 Advanced Polymer Systems, Inc. Polymers with controlled physical state and bioerodibility
US5939453A (en) * 1998-06-04 1999-08-17 Advanced Polymer Systems, Inc. PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers

Also Published As

Publication number Publication date
CA2445638C (en) 2010-02-09
DE60115631D1 (de) 2006-01-12
AU2001261516A1 (en) 2001-11-20
WO2001085139A2 (en) 2001-11-15
EP1280558A2 (de) 2003-02-05
EP1280558B1 (de) 2005-12-07
WO2001085139A3 (en) 2002-04-18
ES2253381T3 (es) 2006-06-01
ATE311904T1 (de) 2005-12-15
DE60115631T2 (de) 2006-08-10
CA2445638A1 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
TW200616650A (en) Semi-solid delivery vehicle and pharmaceutical compositions
ATE391708T1 (de) Verbindungen und gemische zur verabreichung eines aktiven agens
DK1280558T3 (da) Halvfast indgivelsesvehikel og farmaceutiske sammensætninger
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
DE60038183D1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
DE60021059D1 (de) Hydrogelpartikel formulierungen
DK1021204T3 (da) Bioadhæsive præparater og fremgangsmåder til topisk administration af aktive midler
ES2110377T1 (es) Formulacion galenica de fenofibrato y aplicacion de la misma.
BR0107869A (pt) Composições farmacêuticas eletrogiradas
BRPI0108435B8 (pt) formulação e uso de entecavir de baixa dose
WO2007133751A3 (en) Base-stabilized polyorthoester formulations
DE60019334D1 (de) Antivirale arznei
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
ATE299740T1 (de) Kombination aus einem no-donor und einem antioxidans zur behanndlung sexueller störungen
SE9900961D0 (sv) Novel compounds
BRPI0008228B8 (pt) composição farmacêutica contendo n-benzoil estaurosporina e agentes solubilizantes
WO2005007072A3 (en) Methods and pharmaceutical compositions for healing wounds
SE9802208D0 (sv) Novel compounds
ATE356637T1 (de) Supramolekulare komplexe enthaltende arzneimittel
DK1414467T3 (da) Topisk behandling af mastalgi
BR0007452A (pt) Uso de melagatrano ou de um derivado farmaceuticamente aceitável ou pró-droga do mesmo, método de tratamento de inflamação, e, formulação farmacêutica para uso no tratamento de inflamação
ATE353224T1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
SE0001916D0 (sv) Novel formulation